Detalhe da pesquisa
1.
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.
J Transl Med
; 22(1): 241, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443917
2.
Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry.
J Rheumatol
; 51(5): 452-461, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359941
3.
Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.
Immunol Rev
; 294(1): 106-123, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930524
4.
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Ann Rheum Dis
; 82(7): 920-926, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019614
5.
Baseline predictors of disease severity in immune checkpoint inhibitor-induced inflammatory arthritis.
Rheumatology (Oxford)
; 2023 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647635
6.
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.
Lancet Oncol
; 21(8): e398-e404, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32758477
7.
Treatment of immune checkpoint inhibitor-induced inflammatory arthritis.
Curr Opin Rheumatol
; 32(3): 315-320, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32168068
8.
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation.
Ann Rheum Dis
; 79(3): 332-338, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31540935
9.
Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis.
Rheumatology (Oxford)
; 58(3): 476-480, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30508191
10.
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse Events.
J Natl Compr Canc Netw
; 17(6): 712-720, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200355
11.
Response to: Correspondence on "Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation" by Braaten et al.
Ann Rheum Dis
; 81(1): e14, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959594
12.
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.
Ann Rheum Dis
; 76(1): 43-50, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27307501
13.
Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?
Ann Rheum Dis
; 78(6): 860-862, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659050
14.
Anti-Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis.
ACR Open Rheumatol
; 6(2): 81-90, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058274
15.
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management.
Rheum Dis Clin North Am
; 50(2): 269-279, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670725
16.
Corticosteroid-resistant immune-related adverse events: a systematic review.
J Immunother Cancer
; 12(1)2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233099
17.
Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis.
Semin Arthritis Rheum
; 67: 152460, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733668
18.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
J Immunother Cancer
; 12(4)2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599660
19.
A Model to Predict Future Biologic or Targeted Synthetic DMARD Switch at a Subsequent Clinic Visit in Rheumatoid Arthritis.
Rheumatol Ther
; 10(6): 1669-1681, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858006
20.
Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team.
J Cancer Res Clin Oncol
; 149(2): 877-883, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102989